Endothelial dysfunction occurs in peripheral circulation patients with acute and stable coronary artery disease

Panuratn Thanyasiri1, David S Celermajer, Mark R Adams

  • 1Dept. of Cardiology, Royal Prince Alfred Hospital, Missenden Rd., Camperdown 2050, Sydney, Australia.

Insights

Acute coronary syndromes (ACS) impair femoral artery function, similar to stable coronary artery disease. This study found endothelial dysfunction and reduced tissue-type plasminogen activator (t-PA) release in ACS patients, indicating systemic vascular impairment.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Clinical Investigation

Background:

  • Atherosclerosis is a systemic inflammatory condition affecting blood vessels.
  • Acute coronary syndromes (ACS) are linked to inflammatory markers, potentially impacting peripheral vascular function.
  • The extent of vascular dysfunction in ACS beyond stable disease is not fully understood.

Purpose of the Study:

  • To investigate whether femoral vascular reactivity and fibrinolytic capacity are impaired in ACS patients compared to stable coronary artery disease (SAP) and control groups.
  • To assess endothelial and smooth muscle function in the femoral artery of patients with different coronary syndromes.
  • To evaluate tissue-type plasminogen activator (t-PA) release in response to vascular stimulation.

Main Methods:

  • Recruited 42 patients into three groups: stable coronary syndromes (SAP), acute coronary syndromes (ACS), and angiographically normal coronary arteries (controls).
  • Assessed femoral artery endothelial and smooth muscle function using acetylcholine (ACh) and nitroglycerin (GTN) infusions post-coronary angiography.
  • Measured t-PA release by comparing arterial and venous concentrations before and after stimulation.

Main Results:

  • ACS patients exhibited significantly higher C-reactive protein levels and reduced net t-PA release at baseline compared to controls.
  • Endothelium-dependent dilatation was significantly impaired in both ACS and SAP groups compared to controls.
  • Stimulation of t-PA release by ACh and GTN occurred only in control subjects, not in ACS or SAP patients, indicating impaired fibrinolytic capacity.

Conclusions:

  • Coronary artery disease, both acute and stable, is associated with systemic endothelial dysfunction.
  • Impaired endothelium-dependent vasodilation and blunted stimulation of t-PA release are equally severe in ACS and stable coronary patients.
  • These findings highlight the systemic nature of endothelial dysfunction in coronary artery disease.

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...